Ocugen, Inc. Files 8-K on Financials
Ticker: OCGN · Form: 8-K · Filed: Nov 5, 2025 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | Nov 5, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: OCGN
TL;DR
OCGN filed an 8-K on Nov 5, 2025, reporting financial condition and results. Details TBD.
AI Summary
Ocugen, Inc. filed an 8-K on November 5, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This 8-K filing signals that Ocugen, Inc. is providing updated information regarding its financial performance and condition to the SEC and its investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report of operations and financial condition, not indicating any immediate adverse events.
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- November 5, 2025 (date) — Date of Report
- 11 Great Valley Parkway Malvern, Pennsylvania 19355 (address) — Principal Executive Office
- 001-36751 (identifier) — SEC File Number
FAQ
What specific financial results are being reported by Ocugen, Inc. in this 8-K?
The provided text of the 8-K filing does not contain specific financial results; it only indicates that the report pertains to 'Results of Operations and Financial Condition'.
When was this 8-K report filed by Ocugen, Inc.?
The 8-K report was filed on November 5, 2025.
What is the principal executive office address for Ocugen, Inc. as listed in the filing?
The principal executive office address is 11 Great Valley Parkway, Malvern, Pennsylvania 19355.
What is the SEC file number for Ocugen, Inc.?
The SEC file number for Ocugen, Inc. is 001-36751.
What other items are included in this 8-K filing besides Results of Operations and Financial Condition?
In addition to 'Results of Operations and Financial Condition', the filing also includes 'Financial Statements and Exhibits'.
Filing Stats: 612 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-11-05 07:30:48
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share OCGN The Nasdaq
Filing Documents
- tm2530208d1_8k.htm (8-K) — 24KB
- tm2530208d1_ex99-1.htm (EX-99.1) — 63KB
- tm2530208d1_ex99-2.htm (EX-99.2) — 21KB
- tm2530208d1_ex99-2img001.jpg (GRAPHIC) — 135KB
- tm2530208d1_ex99-2img002.jpg (GRAPHIC) — 307KB
- tm2530208d1_ex99-2img003.jpg (GRAPHIC) — 137KB
- tm2530208d1_ex99-2img004.jpg (GRAPHIC) — 174KB
- tm2530208d1_ex99-2img005.jpg (GRAPHIC) — 155KB
- tm2530208d1_ex99-2img006.jpg (GRAPHIC) — 156KB
- tm2530208d1_ex99-2img007.jpg (GRAPHIC) — 183KB
- tm2530208d1_ex99-2img008.jpg (GRAPHIC) — 154KB
- tm2530208d1_ex99-2img009.jpg (GRAPHIC) — 116KB
- tm2530208d1_ex99-2img010.jpg (GRAPHIC) — 122KB
- tm2530208d1_ex99-2img011.jpg (GRAPHIC) — 134KB
- tm2530208d1_ex99-2img012.jpg (GRAPHIC) — 45KB
- tm2530208d1_ex99-2img013.jpg (GRAPHIC) — 328KB
- tm2530208d1_ex99-2img014.jpg (GRAPHIC) — 47KB
- tm2530208d1_ex99-2img015.jpg (GRAPHIC) — 41KB
- 0001104659-25-106664.txt ( ) — 3363KB
- ocgn-20251105.xsd (EX-101.SCH) — 3KB
- ocgn-20251105_lab.xml (EX-101.LAB) — 33KB
- ocgn-20251105_pre.xml (EX-101.PRE) — 22KB
- tm2530208d1_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On November 5, 2025, Ocugen, Inc. (the "Company") issued a press release announcing certain financial results for the quarter ended September 30, 2025. The Company has scheduled a conference call and webcast for 8:30 a.m. Eastern Time on November 5, 2025, to discuss these financial results and business updates. The Company will use presentation materials in connection with the conference call and webcast, which presentation materials will be posted on the Company's website at www.ocugen.com. Copies of the press release and presentation materials are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K (this "Report") and incorporated herein by reference. The information disclosed under Item 2.02 of this Report, including Exhibit 99.1 and Exhibit 99.2, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any Company filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. The following exhibits are being furnished herewith: (d) Exhibits Exhibit No. Document 99.1 Press Release of Ocugen, Inc. dated November 5, 2025. 99.2 Earnings Release Presentation issued November 5, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 5, 2025 OCUGEN, INC. By: /s/ Shankar Musunuri Name:Shankar Musunuri Title:Chairman, Chief Executive Officer, & Co-Founder 3